Navigation Links
TVM Capital MENA Marks Inauguration of ProVita International Medical Center
Date:10/12/2011

house with a focus in healthcare to establish operations in the MENA region. The three founding investors of the TVM Capital MENA Healthcare Private Equity Fund are the IFC (International Financing Corporation), GE Healthcare and The Olayan Group.

The second TVM Capital MENA investment in the region, Bourn Hall International, had a soft opening of its first in-vitro-fertilization (IVF) clinic in Kochi, Kerala, India in July 2011 and is currently building out additional facilities in Delhi and Dubai. The founders of BHI invented IVF in 1978 with the first successful birth of a child conceived through an IVF procedure. As the ultimate testament of Bourn Hall's world-leading expertise in the field of fertility, its founder, Dr. Bob Edwards, was awarded in 2010 the Nobel Prize in medicine for the invention of IVF.

Notes to editor

TVM Capital MENA Ltd. is a private equity firm focusing on investments in health care in the Middle East and North Africa (MENA).  TVM Capital MENA operates out of the Dubai International Financial Center and is licensed and regulated by the DFSA.  The team of TVM Capital MENA is affiliated to the international Life Science Practice of TVM Capital. The TVM Capital Life Science Practice currently manages €820 million from more than 50 investors. The investment professionals draw upon the experience, international approach and demonstrated success of about 80 exits from almost 120 investments. Exits include nearly 40 initial public offerings on the NASDAQ, and the London, Frankfurt, Zurich and Vienna Stock Exchanges and 25 trade sales and mergers. TVM Capital Life Science operates with an integrated team from its headquarters in Munich and a representative office in Boston. The team combines long-standing international investment experience and operating track records with extensive networks in and knowledge of the MENA region.

More information please vis
'/>"/>

SOURCE TVM Capital MENA
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. MGT Capital Investments Reports Second Quarter 2008 Financial Results and Provides Update on Recent Developments
2. TVM Capital, Signet Healthcare Partners and Paul Capital Healthcare Enter into euro 26 Million Financing of SpePharm
3. Sonus Pharmaceuticals and OncoGenex Technologies complete business combination; OncoGenex Pharmaceuticals to commence trading on NASDAQ Capital Market today
4. Sinobiomed Retains CB Capital Partners as Financial Advisor to Maximize Shareholder Value
5. Aegis Analytical Corp. Showcases Discoverant at Inaugural Venture Capital in the Rockies Fall
6. Tengion Featured as Model of Innovation and Success at 35th Anniversary Celebration of the National Venture Capital Association
7. Aerolase Retains SMH Capital Inc. to Advise on Corporate Expansion
8. CPC of America, Inc. to Explore Strategic Alternatives; Appoints FTI Capital Advisors to Assess Potential Opportunities
9. Solos Endoscopy, Inc. Implements Strategy to Capitalize on $30 Billion Minimally Invasive Surgical Product Market
10. EntreMed Announces Stock Listing Transfer to Nasdaq Capital Market
11. Simbionix Raises Largest Amount in Companys History in Venture Capital to Accelerate Growth
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... Aug. 27, 2015 /PRNewswire/ - BIOREM Inc. (TSXV: BRM) ("Biorem" or ... periods ended June 30, 2015. Biorem,s complete second quarter financial statements ... FINANCIAL HIGHLIGHTS: in ,000,s except earnings per shareThree-months ended , Six ... , 2015 , 2014 Revenue , ... 4,433 Gross profit , 1,656 , 56 ...
(Date:8/27/2015)... PARK, N.C. , Aug. 27, 2015 /PRNewswire/ ... the decision by FedEx, UPS and The US ... certain biological specimens classified as ,select agents, by ... long history of handling these sensitive shipments. ... of global transportation regulations, trained and certified personnel ...
(Date:8/26/2015)... (PRWEB) , ... August 26, 2015 , ... ... is increasing its investment in the development and manufacture of highly valued cardiac ... The company’s scientific team's extensive expertise with protein chemistry has led to the ...
(Date:8/26/2015)... -- China Cord Blood Corporation (NYSE: CO ) ... of cord blood collection, laboratory testing, hematopoietic stem cell ... the Company has been informed that Magnum Opus 2 ... Mr. Yuen Kam, chairman of the board of directors ... "Shares") of  Excellent China Healthcare Investment Limited ("KKR SPV") ...
Breaking Biology Technology:BIOREM Reports $718,000 Net Earnings for the Second Quarter 2BIOREM Reports $718,000 Net Earnings for the Second Quarter 3Marken Ensures Safe Transportation Of Select Agents And Toxins 2Lee Biosolutions Announces Increased Investment in the Development and Manufacturing of Biomarkers Used in Early Detection Of Heart Disease 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 2China Cord Blood Corporation Receives Notice of Transactions Regarding its 7% Senior Convertible Notes Due 2017 3
... Systems, Inc., a technology leader in developing novel chip-on-catheter ... a new 510(k) clearance for its Third Eye(R) Retroscope(R) ... cancerous and pre-cancerous polyps in the colon. This ... the FDA to enhance polyp detection when used in ...
... college-aged women expert guidance in career, financial planning ... young women enter the "real world" expecting that ... it comes to their careers, finances and relationships. ... often happens -- a looming problem especially in ...
... Feb. 17 GeneGo, Inc., the leading systems ... licensed 250 manually curated pathway maps from GeneGo, ... Available at www.millipore.com/pathways , the tool links ... well as relevant bioinformatics content to related biological ...
Cached Biology Technology:Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 2Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 3Avantis Medical Systems Announces FDA 510(k) Clearance for the Third Eye(R) Retroscope(R) for Improved Polyp Detection in the Colon 4Helping Young Women Succeed in Today's Unpredictable World 2Helping Young Women Succeed in Today's Unpredictable World 3Helping Young Women Succeed in Today's Unpredictable World 4Millipore Launches an Interactive Biological Pathway Tool Using GeneGo's Manually Curated Pathway Maps 2Millipore Launches an Interactive Biological Pathway Tool Using GeneGo's Manually Curated Pathway Maps 3
(Date:8/4/2015)... 2015  AMRI (NASDAQ: AMRI ) today reported financial and ... Highlights: , Second quarter contract revenue of ... , Adjusted contract margins of 26 % ... a $0.05 decrease in EPS from royalties in the current quarter ... "We are very pleased to present another strong financial ...
(Date:7/31/2015)... juli 2015 Den 10. internationale konference om ... den 22. - 25. oktober i Shenzhen ... 10-års fødselsdag i år. Siden starten i 2006 er ... på ,omik,-feltet, og er en af de mest dynamiske, ... fokuserer på nylige gennembrud og fremskridt inden for ,omik,-forskning, ...
(Date:7/31/2015)... 31 de julho de 2015 A 10 ... ) será realizada pela BGI de 22-25 de outubro de ... A conferência está celebrando seu 10 o. ... ICG se tornou uma das reuniões mais influentes do ... científicos mais dinâmicos, entusiastas e prazerosos. ...
Breaking Biology News(10 mins):AMRI Announces Second Quarter 2015 Results 2AMRI Announces Second Quarter 2015 Results 3AMRI Announces Second Quarter 2015 Results 4AMRI Announces Second Quarter 2015 Results 5AMRI Announces Second Quarter 2015 Results 6AMRI Announces Second Quarter 2015 Results 7AMRI Announces Second Quarter 2015 Results 8AMRI Announces Second Quarter 2015 Results 9AMRI Announces Second Quarter 2015 Results 10AMRI Announces Second Quarter 2015 Results 11AMRI Announces Second Quarter 2015 Results 12AMRI Announces Second Quarter 2015 Results 13AMRI Announces Second Quarter 2015 Results 14AMRI Announces Second Quarter 2015 Results 15AMRI Announces Second Quarter 2015 Results 16AMRI Announces Second Quarter 2015 Results 17AMRI Announces Second Quarter 2015 Results 18AMRI Announces Second Quarter 2015 Results 19AMRI Announces Second Quarter 2015 Results 20AMRI Announces Second Quarter 2015 Results 21AMRI Announces Second Quarter 2015 Results 22AMRI Announces Second Quarter 2015 Results 23AMRI Announces Second Quarter 2015 Results 24Den 10. internationale konference om Genomics (ICG-10) åbner i oktober 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 2A 10a. Conferência Internacional sobre Genômica (ICG-10) será em outubro 3
... National Institutes of Health has awarded 23 grants for ... five years. The projects will focus on determining the ... medicine. The awards are part of the ... 2000 with the main goal of developing highly efficient, ...
... the millions of Americans with high blood pressure, more help ... published in the October 2010 print issue of The ... called P450, metabolizes arachidonic acid in our blood vessel walls ... (EET)which in mice, turns off genes responsible for vascular inflammation ...
... Arizona State University has been awarded a $7.7 million ... of General Medical Sciences, part of the National Institutes of ... a key role in protection against infectious diseases. As ... Chemistry and Biochemistry in the College of Liberal Arts and ...
Cached Biology News:NIH grants will advance studies of the form and function of proteins 2NIH grants will advance studies of the form and function of proteins 3Scientists discover a new way our bodies control blood pressure: the P450-EET system 2NIH funds center at Arizona State to battle infectious diseases 2NIH funds center at Arizona State to battle infectious diseases 3
... Mouse monoclonal antibody raised ... Immunogen: ... 206 a.a) partial recombinant protein ... Accession Number: NM_005802 ...
Mouse monoclonal antibody raised against a partial recombinant DENR. NCBI Entrez Gene ID = DENR...
Mouse monoclonal antibody raised against a full length recombinant SNAPC5. NCBI Entrez Gene ID = SNAPC5...
Agarose II (Low Melt)...
Biology Products: